3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Recurrence
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
ruxolitinib
3
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Cyclosporine
2
umbralisib
1
itacitinib
1
iadademstat
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Specimen Handling
1
Sirolimus
1
Panobinostat
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
INCB039110
1
Hyperbaric Oxygenation
1
Etoposide
1
CPI-0610
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
Thiotepa
×
30 days
×
Clear all
No trials found.